Eli Lilly and Co Stock: A Deep Dive Into Analyst Perspectives (17 Ratings)
Portfolio Pulse from Benzinga Insights
Analysts' ratings for Eli Lilly and Co (NYSE:LLY) show a mix of bullish and somewhat bullish sentiments, with recent price targets indicating an upward trend. The average 12-month price target is $865.18, reflecting a 5.99% increase from the previous average. Key financial metrics such as revenue growth, net margin, ROE, and ROA are strong, but the company faces challenges with a high debt-to-equity ratio.
June 12, 2024 | 9:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Analysts' ratings for Eli Lilly and Co (NYSE:LLY) show a mix of bullish and somewhat bullish sentiments, with recent price targets indicating an upward trend. The average 12-month price target is $865.18, reflecting a 5.99% increase from the previous average. Key financial metrics such as revenue growth, net margin, ROE, and ROA are strong, but the company faces challenges with a high debt-to-equity ratio.
The majority of analysts have a bullish or somewhat bullish outlook on Eli Lilly, with recent price targets showing an upward trend. The company's strong financial metrics, including revenue growth, net margin, ROE, and ROA, support a positive short-term impact on the stock price. However, the high debt-to-equity ratio poses a risk that investors should monitor.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100